Literature DB >> 8620831

[Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].

M Demandt, H Wandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8620831

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  4 in total

1.  Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

Authors:  Bernd Kasper; Christoph Harter; Julia Meissner; Frauke Bellos; Fatime Krasniqi; Anthony D Ho; Gerlinde Egerer
Journal:  Support Care Cancer       Date:  2004-01-16       Impact factor: 3.603

Review 2.  Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Authors:  Karen I Sweiss; Rakesh Beri; Stacy S Shord
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Authors:  J Pelgrims; F De Vos; J Van den Brande; D Schrijvers; A Prové; J B Vermorken
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.

Authors:  Cindy Banh; Kendall Valsvik; Alejandra Arredondo; Kassie Notbohm; Emad Elquza; Hani Babiker; Andrew Kraft; Alejandro Recio Boiles; Daniel Persky; Alicia Ortega; Ali McBride
Journal:  Support Care Cancer       Date:  2021-11-26       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.